Kraft Davis & Associates’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Buy
374
+17
+5% +$17.4K 0.1% 94
2026
Q1
$337K Buy
357
+25
+8% +$25.3K 0.07% 109
2025
Q4
$357K Buy
332
+41
+14% +$39.2K 0.08% 114
2025
Q3
$246K Sell
291
-43
-13% -$32K 0.06% 129
2025
Q2
$270K Buy
334
+41
+14% +$31.9K 0.07% 119
2025
Q1
$241K Sell
293
-68
-19% -$56.6K 0.08% 113
2024
Q4
$315K Buy
361
+68
+23% +$56.3K 0.09% 96
2024
Q3
$248K Hold
293
0.07% 124
2024
Q2
$236K Sell
293
-3
-1% -$2.4K 0.07% 125
2024
Q1
$225K Buy
+296
New +$211K 0.07% 125

Other funds holding LLY

Kraft Davis & Associates's LLY Position: Q2 2026 in Review

Kraft Davis & Associates increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $17.4K and bringing the position to 374 shares worth $457K. The position accounts for 0.1% of the portfolio, ranked #94.

Kraft Davis & Associates first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kraft Davis & Associates held 374 shares of Eli Lilly worth $457K as of Q2 2026.
  • Kraft Davis & Associates bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.1% of Kraft Davis & Associates's portfolio in Q2 2026, its #94 holding.
  • Kraft Davis & Associates first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kraft Davis & Associates's 13F filing for Q2 2026, filed 9 Jul 2026.